A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease by Marrinan, S, Otiker, T, Vasist, L, Gibson, R, Sarai, B, Barton, M, Richards, D, Hellström, P, Nyholm, D, Dukes, G, Burn, D

Nutrition adequacy therapeutic enhancement in the critically ill: a randomized double‐blind, placebo‐controlled trial of the motilin receptor agonist camicinal (GSK962040): the NUT... by Deane, A, Lamontagne, F, Dukes, G, Neil, D, Vasist, L, Barton, M, Hacquoil, K, Ou, X, Richards, D, Stelfox, H, Mehta, S, Day, A, Chapman, M, Heyland, D

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours. by Blagden, S, Molife, L, Seebaran, A, Payne, M, Reid, A, Protheroe, A, Vasist, L, Williams, D, Bowen, C, Kathman, S, Hodge, J, Dar, M, de Bono, J, Middleton, MR